nodes	percent_of_prediction	percent_of_DWPC	metapath
Clindamycin—CYP3A4—Topotecan—lung cancer	0.0907	0.142	CbGbCtD
Clindamycin—CYP3A4—Gefitinib—lung cancer	0.083	0.13	CbGbCtD
Clindamycin—CYP3A4—Teniposide—lung cancer	0.0805	0.126	CbGbCtD
Clindamycin—CYP3A4—Vinorelbine—lung cancer	0.0639	0.1	CbGbCtD
Clindamycin—CYP3A4—Crizotinib—lung cancer	0.0509	0.0796	CbGbCtD
Clindamycin—CYP3A4—Erlotinib—lung cancer	0.0491	0.0768	CbGbCtD
Clindamycin—CYP3A4—Paclitaxel—lung cancer	0.0449	0.0703	CbGbCtD
Clindamycin—CYP3A4—Irinotecan—lung cancer	0.0443	0.0694	CbGbCtD
Clindamycin—CYP3A4—Vinblastine—lung cancer	0.0394	0.0617	CbGbCtD
Clindamycin—CYP3A4—Etoposide—lung cancer	0.0355	0.0556	CbGbCtD
Clindamycin—CYP3A4—Docetaxel—lung cancer	0.0325	0.0508	CbGbCtD
Clindamycin—CYP3A4—Doxorubicin—lung cancer	0.0242	0.0379	CbGbCtD
Clindamycin—CYP3A4—Felbamate Metabolism—CYP2E1—lung cancer	0.000952	0.0907	CbGpPWpGaD
Clindamycin—CYP3A4—Codeine and Morphine Metabolism—ABCC3—lung cancer	0.000482	0.0459	CbGpPWpGaD
Clindamycin—CYP3A4—Codeine and Morphine Metabolism—UGT1A1—lung cancer	0.000453	0.0432	CbGpPWpGaD
Clindamycin—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—lung cancer	0.000425	0.0405	CbGpPWpGaD
Clindamycin—CYP3A4—Xenobiotics—CYP2A7—lung cancer	0.000306	0.0291	CbGpPWpGaD
Clindamycin—Hypotension—Irinotecan—lung cancer	0.000295	0.00084	CcSEcCtD
Clindamycin—Dermatitis exfoliative—Doxorubicin—lung cancer	0.000293	0.000836	CcSEcCtD
Clindamycin—Vomiting—Vinblastine—lung cancer	0.000293	0.000834	CcSEcCtD
Clindamycin—Dizziness—Erlotinib—lung cancer	0.000293	0.000834	CcSEcCtD
Clindamycin—Anaemia—Paclitaxel—lung cancer	0.000291	0.00083	CcSEcCtD
Clindamycin—Erythema multiforme—Docetaxel—lung cancer	0.00029	0.000827	CcSEcCtD
Clindamycin—Dermatitis bullous—Doxorubicin—lung cancer	0.00029	0.000826	CcSEcCtD
Clindamycin—CYP3A4—Irinotecan Pathway—UGT1A1—lung cancer	0.00029	0.0276	CbGpPWpGaD
Clindamycin—Vertigo—Etoposide—lung cancer	0.000289	0.000823	CcSEcCtD
Clindamycin—Headache—Vinblastine—lung cancer	0.000288	0.000822	CcSEcCtD
Clindamycin—Toxic epidermal necrolysis—Methotrexate—lung cancer	0.000288	0.000821	CcSEcCtD
Clindamycin—Leukopenia—Etoposide—lung cancer	0.000288	0.00082	CcSEcCtD
Clindamycin—Hypotension—Gemcitabine—lung cancer	0.000287	0.000818	CcSEcCtD
Clindamycin—Anaphylactic shock—Cisplatin—lung cancer	0.000286	0.000816	CcSEcCtD
Clindamycin—Anaphylactoid reaction—Doxorubicin—lung cancer	0.000286	0.000815	CcSEcCtD
Clindamycin—Flushing—Docetaxel—lung cancer	0.000285	0.000812	CcSEcCtD
Clindamycin—Vomiting—Topotecan—lung cancer	0.000284	0.00081	CcSEcCtD
Clindamycin—Vertigo—Paclitaxel—lung cancer	0.000283	0.000807	CcSEcCtD
Clindamycin—Leukopenia—Paclitaxel—lung cancer	0.000282	0.000804	CcSEcCtD
Clindamycin—Rash—Topotecan—lung cancer	0.000282	0.000803	CcSEcCtD
Clindamycin—Hypersensitivity—Vinorelbine—lung cancer	0.000282	0.000803	CcSEcCtD
Clindamycin—Dermatitis—Topotecan—lung cancer	0.000282	0.000803	CcSEcCtD
Clindamycin—Vomiting—Erlotinib—lung cancer	0.000281	0.000802	CcSEcCtD
Clindamycin—Dyspnoea—Irinotecan—lung cancer	0.000281	0.000802	CcSEcCtD
Clindamycin—Thrombocytopenia—Cisplatin—lung cancer	0.00028	0.000799	CcSEcCtD
Clindamycin—Headache—Topotecan—lung cancer	0.00028	0.000798	CcSEcCtD
Clindamycin—Rash—Erlotinib—lung cancer	0.000279	0.000795	CcSEcCtD
Clindamycin—Dermatitis—Erlotinib—lung cancer	0.000279	0.000794	CcSEcCtD
Clindamycin—Dyspepsia—Irinotecan—lung cancer	0.000278	0.000791	CcSEcCtD
Clindamycin—Hypertension—Etoposide—lung cancer	0.000278	0.000791	CcSEcCtD
Clindamycin—Headache—Erlotinib—lung cancer	0.000277	0.00079	CcSEcCtD
Clindamycin—Asthenia—Vinorelbine—lung cancer	0.000274	0.000782	CcSEcCtD
Clindamycin—Dyspnoea—Gemcitabine—lung cancer	0.000274	0.000781	CcSEcCtD
Clindamycin—Eosinophilia—Methotrexate—lung cancer	0.000274	0.00078	CcSEcCtD
Clindamycin—Nausea—Vinblastine—lung cancer	0.000273	0.000779	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Irinotecan—lung cancer	0.000272	0.000776	CcSEcCtD
Clindamycin—Hypertension—Paclitaxel—lung cancer	0.000272	0.000776	CcSEcCtD
Clindamycin—Fatigue—Irinotecan—lung cancer	0.000272	0.000775	CcSEcCtD
Clindamycin—Pruritus—Vinorelbine—lung cancer	0.000271	0.000771	CcSEcCtD
Clindamycin—Discomfort—Etoposide—lung cancer	0.00027	0.000771	CcSEcCtD
Clindamycin—Constipation—Irinotecan—lung cancer	0.00027	0.000769	CcSEcCtD
Clindamycin—Pain—Irinotecan—lung cancer	0.00027	0.000769	CcSEcCtD
Clindamycin—Hypotension—Cisplatin—lung cancer	0.000268	0.000763	CcSEcCtD
Clindamycin—Erythema—Docetaxel—lung cancer	0.000267	0.000761	CcSEcCtD
Clindamycin—Nausea—Topotecan—lung cancer	0.000266	0.000757	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000265	0.000756	CcSEcCtD
Clindamycin—Discomfort—Paclitaxel—lung cancer	0.000265	0.000756	CcSEcCtD
Clindamycin—Abdominal discomfort—Methotrexate—lung cancer	0.000265	0.000755	CcSEcCtD
Clindamycin—Fatigue—Gemcitabine—lung cancer	0.000265	0.000755	CcSEcCtD
Clindamycin—CYP3A4—Aflatoxin B1 metabolism—GSTM1—lung cancer	0.000265	0.0252	CbGpPWpGaD
Clindamycin—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC3—lung cancer	0.000264	0.0251	CbGpPWpGaD
Clindamycin—Cardiac arrest—Doxorubicin—lung cancer	0.000263	0.00075	CcSEcCtD
Clindamycin—Constipation—Gemcitabine—lung cancer	0.000263	0.000749	CcSEcCtD
Clindamycin—Pain—Gemcitabine—lung cancer	0.000263	0.000749	CcSEcCtD
Clindamycin—Nausea—Erlotinib—lung cancer	0.000263	0.000749	CcSEcCtD
Clindamycin—Anaphylactic shock—Etoposide—lung cancer	0.000262	0.000748	CcSEcCtD
Clindamycin—Diarrhoea—Vinorelbine—lung cancer	0.000262	0.000746	CcSEcCtD
Clindamycin—Dysgeusia—Docetaxel—lung cancer	0.000262	0.000746	CcSEcCtD
Clindamycin—Back pain—Docetaxel—lung cancer	0.000258	0.000737	CcSEcCtD
Clindamycin—Dysuria—Methotrexate—lung cancer	0.000258	0.000737	CcSEcCtD
Clindamycin—Neutropenia—Methotrexate—lung cancer	0.000258	0.000737	CcSEcCtD
Clindamycin—Gastrointestinal pain—Irinotecan—lung cancer	0.000258	0.000735	CcSEcCtD
Clindamycin—Anaphylactic shock—Paclitaxel—lung cancer	0.000257	0.000733	CcSEcCtD
Clindamycin—Thrombocytopenia—Etoposide—lung cancer	0.000257	0.000732	CcSEcCtD
Clindamycin—Muscle spasms—Docetaxel—lung cancer	0.000257	0.000732	CcSEcCtD
Clindamycin—Upper respiratory tract infection—Methotrexate—lung cancer	0.000257	0.000732	CcSEcCtD
Clindamycin—Dyspnoea—Cisplatin—lung cancer	0.000255	0.000728	CcSEcCtD
Clindamycin—CYP3A4—Estrogen metabolism—GSTA1—lung cancer	0.000255	0.0243	CbGpPWpGaD
Clindamycin—Dry skin—Doxorubicin—lung cancer	0.000254	0.000723	CcSEcCtD
Clindamycin—Dizziness—Vinorelbine—lung cancer	0.000253	0.000721	CcSEcCtD
Clindamycin—Abdominal pain upper—Doxorubicin—lung cancer	0.000253	0.000721	CcSEcCtD
Clindamycin—Photosensitivity reaction—Methotrexate—lung cancer	0.000252	0.000719	CcSEcCtD
Clindamycin—Thrombocytopenia—Paclitaxel—lung cancer	0.000252	0.000718	CcSEcCtD
Clindamycin—CYP3A4—Irinotecan Pathway—ABCG2—lung cancer	0.000251	0.0239	CbGpPWpGaD
Clindamycin—Body temperature increased—Irinotecan—lung cancer	0.000249	0.000711	CcSEcCtD
Clindamycin—Abdominal pain—Irinotecan—lung cancer	0.000249	0.000711	CcSEcCtD
Clindamycin—Toxic epidermal necrolysis—Doxorubicin—lung cancer	0.000249	0.000711	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Cisplatin—lung cancer	0.000247	0.000705	CcSEcCtD
Clindamycin—Anaemia—Docetaxel—lung cancer	0.000247	0.000704	CcSEcCtD
Clindamycin—CYP3A4—Codeine and Morphine Metabolism—ABCB1—lung cancer	0.000245	0.0234	CbGpPWpGaD
Clindamycin—Hypotension—Etoposide—lung cancer	0.000245	0.000699	CcSEcCtD
Clindamycin—Pain—Cisplatin—lung cancer	0.000245	0.000698	CcSEcCtD
Clindamycin—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.000244	0.000696	CcSEcCtD
Clindamycin—Vomiting—Vinorelbine—lung cancer	0.000243	0.000693	CcSEcCtD
Clindamycin—Body temperature increased—Gemcitabine—lung cancer	0.000243	0.000692	CcSEcCtD
Clindamycin—Rash—Vinorelbine—lung cancer	0.000241	0.000687	CcSEcCtD
Clindamycin—Dermatitis—Vinorelbine—lung cancer	0.000241	0.000687	CcSEcCtD
Clindamycin—Abdominal distension—Doxorubicin—lung cancer	0.000241	0.000687	CcSEcCtD
Clindamycin—Hypotension—Paclitaxel—lung cancer	0.00024	0.000685	CcSEcCtD
Clindamycin—Headache—Vinorelbine—lung cancer	0.00024	0.000683	CcSEcCtD
Clindamycin—Leukopenia—Docetaxel—lung cancer	0.000239	0.000682	CcSEcCtD
Clindamycin—Eosinophilia—Doxorubicin—lung cancer	0.000237	0.000675	CcSEcCtD
Clindamycin—CYP3A4—Estrogen metabolism—UGT1A1—lung cancer	0.000237	0.0226	CbGpPWpGaD
Clindamycin—Dyspnoea—Etoposide—lung cancer	0.000234	0.000667	CcSEcCtD
Clindamycin—Epistaxis—Methotrexate—lung cancer	0.000232	0.000662	CcSEcCtD
Clindamycin—Hypersensitivity—Irinotecan—lung cancer	0.000232	0.000662	CcSEcCtD
Clindamycin—Hypertension—Docetaxel—lung cancer	0.000231	0.000657	CcSEcCtD
Clindamycin—Agranulocytosis—Methotrexate—lung cancer	0.00023	0.000655	CcSEcCtD
Clindamycin—Dyspnoea—Paclitaxel—lung cancer	0.000229	0.000654	CcSEcCtD
Clindamycin—Nausea—Vinorelbine—lung cancer	0.000227	0.000648	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Etoposide—lung cancer	0.000227	0.000646	CcSEcCtD
Clindamycin—Dyspepsia—Paclitaxel—lung cancer	0.000226	0.000645	CcSEcCtD
Clindamycin—Body temperature increased—Cisplatin—lung cancer	0.000226	0.000645	CcSEcCtD
Clindamycin—Asthenia—Irinotecan—lung cancer	0.000226	0.000645	CcSEcCtD
Clindamycin—Fatigue—Etoposide—lung cancer	0.000226	0.000645	CcSEcCtD
Clindamycin—Pain—Etoposide—lung cancer	0.000224	0.000639	CcSEcCtD
Clindamycin—Constipation—Etoposide—lung cancer	0.000224	0.000639	CcSEcCtD
Clindamycin—Dysuria—Doxorubicin—lung cancer	0.000224	0.000638	CcSEcCtD
Clindamycin—Neutropenia—Doxorubicin—lung cancer	0.000224	0.000638	CcSEcCtD
Clindamycin—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000222	0.000634	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000222	0.000633	CcSEcCtD
Clindamycin—Fatigue—Paclitaxel—lung cancer	0.000222	0.000632	CcSEcCtD
Clindamycin—Asthenia—Gemcitabine—lung cancer	0.00022	0.000628	CcSEcCtD
Clindamycin—Pain—Paclitaxel—lung cancer	0.00022	0.000627	CcSEcCtD
Clindamycin—Constipation—Paclitaxel—lung cancer	0.00022	0.000627	CcSEcCtD
Clindamycin—Photosensitivity reaction—Doxorubicin—lung cancer	0.000218	0.000623	CcSEcCtD
Clindamycin—Anaphylactic shock—Docetaxel—lung cancer	0.000218	0.000621	CcSEcCtD
Clindamycin—Pruritus—Gemcitabine—lung cancer	0.000217	0.00062	CcSEcCtD
Clindamycin—Diarrhoea—Irinotecan—lung cancer	0.000216	0.000615	CcSEcCtD
Clindamycin—Gastrointestinal pain—Etoposide—lung cancer	0.000215	0.000612	CcSEcCtD
Clindamycin—Thrombocytopenia—Docetaxel—lung cancer	0.000213	0.000608	CcSEcCtD
Clindamycin—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—lung cancer	0.000212	0.0202	CbGpPWpGaD
Clindamycin—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000212	0.000603	CcSEcCtD
Clindamycin—Hypersensitivity—Cisplatin—lung cancer	0.000211	0.000601	CcSEcCtD
Clindamycin—Gastrointestinal pain—Paclitaxel—lung cancer	0.00021	0.0006	CcSEcCtD
Clindamycin—Diarrhoea—Gemcitabine—lung cancer	0.00021	0.000599	CcSEcCtD
Clindamycin—Erythema multiforme—Methotrexate—lung cancer	0.000209	0.000596	CcSEcCtD
Clindamycin—Dizziness—Irinotecan—lung cancer	0.000209	0.000595	CcSEcCtD
Clindamycin—Urticaria—Etoposide—lung cancer	0.000208	0.000594	CcSEcCtD
Clindamycin—Jaundice—Doxorubicin—lung cancer	0.000208	0.000593	CcSEcCtD
Clindamycin—Body temperature increased—Etoposide—lung cancer	0.000207	0.000591	CcSEcCtD
Clindamycin—Abdominal pain—Etoposide—lung cancer	0.000207	0.000591	CcSEcCtD
Clindamycin—Urinary tract infection—Doxorubicin—lung cancer	0.000207	0.000591	CcSEcCtD
Clindamycin—Asthenia—Cisplatin—lung cancer	0.000205	0.000586	CcSEcCtD
Clindamycin—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—lung cancer	0.000205	0.0196	CbGpPWpGaD
Clindamycin—Urticaria—Paclitaxel—lung cancer	0.000204	0.000582	CcSEcCtD
Clindamycin—Hypotension—Docetaxel—lung cancer	0.000204	0.000581	CcSEcCtD
Clindamycin—Abdominal pain—Paclitaxel—lung cancer	0.000203	0.00058	CcSEcCtD
Clindamycin—Body temperature increased—Paclitaxel—lung cancer	0.000203	0.00058	CcSEcCtD
Clindamycin—Epistaxis—Doxorubicin—lung cancer	0.000201	0.000574	CcSEcCtD
Clindamycin—Vomiting—Irinotecan—lung cancer	0.000201	0.000572	CcSEcCtD
Clindamycin—Agranulocytosis—Doxorubicin—lung cancer	0.000199	0.000568	CcSEcCtD
Clindamycin—Rash—Irinotecan—lung cancer	0.000199	0.000567	CcSEcCtD
Clindamycin—Dermatitis—Irinotecan—lung cancer	0.000199	0.000566	CcSEcCtD
Clindamycin—CYP3A4—Tryptophan metabolism—HSD17B10—lung cancer	0.000198	0.0189	CbGpPWpGaD
Clindamycin—Headache—Irinotecan—lung cancer	0.000198	0.000563	CcSEcCtD
Clindamycin—Diarrhoea—Cisplatin—lung cancer	0.000196	0.000559	CcSEcCtD
Clindamycin—Vomiting—Gemcitabine—lung cancer	0.000195	0.000557	CcSEcCtD
Clindamycin—Dyspnoea—Docetaxel—lung cancer	0.000194	0.000554	CcSEcCtD
Clindamycin—Rash—Gemcitabine—lung cancer	0.000194	0.000552	CcSEcCtD
Clindamycin—Dermatitis—Gemcitabine—lung cancer	0.000194	0.000552	CcSEcCtD
Clindamycin—Hypersensitivity—Etoposide—lung cancer	0.000193	0.000551	CcSEcCtD
Clindamycin—Erythema—Methotrexate—lung cancer	0.000193	0.000549	CcSEcCtD
Clindamycin—Headache—Gemcitabine—lung cancer	0.000192	0.000549	CcSEcCtD
Clindamycin—Dyspepsia—Docetaxel—lung cancer	0.000192	0.000547	CcSEcCtD
Clindamycin—Hypersensitivity—Paclitaxel—lung cancer	0.00019	0.00054	CcSEcCtD
Clindamycin—Dysgeusia—Methotrexate—lung cancer	0.000189	0.000537	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Docetaxel—lung cancer	0.000188	0.000537	CcSEcCtD
Clindamycin—Asthenia—Etoposide—lung cancer	0.000188	0.000537	CcSEcCtD
Clindamycin—Fatigue—Docetaxel—lung cancer	0.000188	0.000536	CcSEcCtD
Clindamycin—Nausea—Irinotecan—lung cancer	0.000187	0.000534	CcSEcCtD
Clindamycin—Pain—Docetaxel—lung cancer	0.000186	0.000531	CcSEcCtD
Clindamycin—Constipation—Docetaxel—lung cancer	0.000186	0.000531	CcSEcCtD
Clindamycin—Back pain—Methotrexate—lung cancer	0.000186	0.000531	CcSEcCtD
Clindamycin—Pruritus—Etoposide—lung cancer	0.000186	0.000529	CcSEcCtD
Clindamycin—Asthenia—Paclitaxel—lung cancer	0.000185	0.000526	CcSEcCtD
Clindamycin—Nausea—Gemcitabine—lung cancer	0.000183	0.00052	CcSEcCtD
Clindamycin—Vomiting—Cisplatin—lung cancer	0.000182	0.000519	CcSEcCtD
Clindamycin—Pruritus—Paclitaxel—lung cancer	0.000182	0.000519	CcSEcCtD
Clindamycin—Erythema multiforme—Doxorubicin—lung cancer	0.000181	0.000516	CcSEcCtD
Clindamycin—Rash—Cisplatin—lung cancer	0.000181	0.000515	CcSEcCtD
Clindamycin—Dermatitis—Cisplatin—lung cancer	0.00018	0.000514	CcSEcCtD
Clindamycin—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—lung cancer	0.00018	0.0172	CbGpPWpGaD
Clindamycin—Diarrhoea—Etoposide—lung cancer	0.00018	0.000512	CcSEcCtD
Clindamycin—Gastrointestinal pain—Docetaxel—lung cancer	0.000178	0.000508	CcSEcCtD
Clindamycin—Anaemia—Methotrexate—lung cancer	0.000178	0.000507	CcSEcCtD
Clindamycin—Flushing—Doxorubicin—lung cancer	0.000178	0.000507	CcSEcCtD
Clindamycin—CYP3A4—Xenobiotics—CYP2A6—lung cancer	0.000177	0.0169	CbGpPWpGaD
Clindamycin—Diarrhoea—Paclitaxel—lung cancer	0.000176	0.000502	CcSEcCtD
Clindamycin—Dizziness—Etoposide—lung cancer	0.000173	0.000495	CcSEcCtD
Clindamycin—Vertigo—Methotrexate—lung cancer	0.000173	0.000493	CcSEcCtD
Clindamycin—Abdominal pain—Docetaxel—lung cancer	0.000172	0.000491	CcSEcCtD
Clindamycin—Body temperature increased—Docetaxel—lung cancer	0.000172	0.000491	CcSEcCtD
Clindamycin—Leukopenia—Methotrexate—lung cancer	0.000172	0.000491	CcSEcCtD
Clindamycin—CYP3A4—Tamoxifen metabolism—CYP2A6—lung cancer	0.000171	0.0163	CbGpPWpGaD
Clindamycin—Dizziness—Paclitaxel—lung cancer	0.00017	0.000485	CcSEcCtD
Clindamycin—Nausea—Cisplatin—lung cancer	0.00017	0.000485	CcSEcCtD
Clindamycin—Vomiting—Etoposide—lung cancer	0.000167	0.000475	CcSEcCtD
Clindamycin—Erythema—Doxorubicin—lung cancer	0.000167	0.000475	CcSEcCtD
Clindamycin—CYP3A4—Constitutive Androstane Receptor Pathway—GSTA2—lung cancer	0.000167	0.0159	CbGpPWpGaD
Clindamycin—Rash—Etoposide—lung cancer	0.000165	0.000472	CcSEcCtD
Clindamycin—Dermatitis—Etoposide—lung cancer	0.000165	0.000471	CcSEcCtD
Clindamycin—Headache—Etoposide—lung cancer	0.000164	0.000468	CcSEcCtD
Clindamycin—Flatulence—Doxorubicin—lung cancer	0.000164	0.000468	CcSEcCtD
Clindamycin—Vomiting—Paclitaxel—lung cancer	0.000164	0.000466	CcSEcCtD
Clindamycin—Dysgeusia—Doxorubicin—lung cancer	0.000163	0.000465	CcSEcCtD
Clindamycin—CYP3A4—Estrogen metabolism—NQO1—lung cancer	0.000162	0.0155	CbGpPWpGaD
Clindamycin—Rash—Paclitaxel—lung cancer	0.000162	0.000462	CcSEcCtD
Clindamycin—Dermatitis—Paclitaxel—lung cancer	0.000162	0.000462	CcSEcCtD
Clindamycin—Discomfort—Methotrexate—lung cancer	0.000162	0.000462	CcSEcCtD
Clindamycin—Back pain—Doxorubicin—lung cancer	0.000161	0.00046	CcSEcCtD
Clindamycin—Headache—Paclitaxel—lung cancer	0.000161	0.000459	CcSEcCtD
Clindamycin—Hypersensitivity—Docetaxel—lung cancer	0.000161	0.000458	CcSEcCtD
Clindamycin—Muscle spasms—Doxorubicin—lung cancer	0.00016	0.000457	CcSEcCtD
Clindamycin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC3—lung cancer	0.000159	0.0152	CbGpPWpGaD
Clindamycin—Anaphylactic shock—Methotrexate—lung cancer	0.000157	0.000448	CcSEcCtD
Clindamycin—Asthenia—Docetaxel—lung cancer	0.000156	0.000446	CcSEcCtD
Clindamycin—Nausea—Etoposide—lung cancer	0.000156	0.000444	CcSEcCtD
Clindamycin—Pruritus—Docetaxel—lung cancer	0.000154	0.00044	CcSEcCtD
Clindamycin—Anaemia—Doxorubicin—lung cancer	0.000154	0.000439	CcSEcCtD
Clindamycin—Thrombocytopenia—Methotrexate—lung cancer	0.000154	0.000439	CcSEcCtD
Clindamycin—Nausea—Paclitaxel—lung cancer	0.000153	0.000436	CcSEcCtD
Clindamycin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—lung cancer	0.000151	0.0144	CbGpPWpGaD
Clindamycin—CYP3A4—Xenobiotics—CYP2E1—lung cancer	0.000151	0.0144	CbGpPWpGaD
Clindamycin—Vertigo—Doxorubicin—lung cancer	0.00015	0.000427	CcSEcCtD
Clindamycin—CYP3A4—Constitutive Androstane Receptor Pathway—UGT1A1—lung cancer	0.000149	0.0142	CbGpPWpGaD
Clindamycin—Leukopenia—Doxorubicin—lung cancer	0.000149	0.000425	CcSEcCtD
Clindamycin—Diarrhoea—Docetaxel—lung cancer	0.000149	0.000425	CcSEcCtD
Clindamycin—Hypotension—Methotrexate—lung cancer	0.000147	0.000419	CcSEcCtD
Clindamycin—CYP3A4—Tamoxifen metabolism—CYP2E1—lung cancer	0.000145	0.0138	CbGpPWpGaD
Clindamycin—Dizziness—Docetaxel—lung cancer	0.000144	0.000411	CcSEcCtD
Clindamycin—Hypertension—Doxorubicin—lung cancer	0.000144	0.00041	CcSEcCtD
Clindamycin—Discomfort—Doxorubicin—lung cancer	0.00014	0.0004	CcSEcCtD
Clindamycin—Dyspnoea—Methotrexate—lung cancer	0.00014	0.000399	CcSEcCtD
Clindamycin—Vomiting—Docetaxel—lung cancer	0.000139	0.000395	CcSEcCtD
Clindamycin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—lung cancer	0.000139	0.0132	CbGpPWpGaD
Clindamycin—Dyspepsia—Methotrexate—lung cancer	0.000138	0.000394	CcSEcCtD
Clindamycin—Rash—Docetaxel—lung cancer	0.000137	0.000392	CcSEcCtD
Clindamycin—Dermatitis—Docetaxel—lung cancer	0.000137	0.000391	CcSEcCtD
Clindamycin—Headache—Docetaxel—lung cancer	0.000137	0.000389	CcSEcCtD
Clindamycin—Anaphylactic shock—Doxorubicin—lung cancer	0.000136	0.000388	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Methotrexate—lung cancer	0.000136	0.000387	CcSEcCtD
Clindamycin—Fatigue—Methotrexate—lung cancer	0.000135	0.000386	CcSEcCtD
Clindamycin—Pain—Methotrexate—lung cancer	0.000134	0.000383	CcSEcCtD
Clindamycin—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—lung cancer	0.000134	0.0128	CbGpPWpGaD
Clindamycin—Thrombocytopenia—Doxorubicin—lung cancer	0.000133	0.00038	CcSEcCtD
Clindamycin—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—lung cancer	0.00013	0.0124	CbGpPWpGaD
Clindamycin—Nausea—Docetaxel—lung cancer	0.00013	0.000369	CcSEcCtD
Clindamycin—Gastrointestinal pain—Methotrexate—lung cancer	0.000129	0.000366	CcSEcCtD
Clindamycin—Hypotension—Doxorubicin—lung cancer	0.000127	0.000362	CcSEcCtD
Clindamycin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—lung cancer	0.000127	0.0121	CbGpPWpGaD
Clindamycin—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—lung cancer	0.000125	0.0119	CbGpPWpGaD
Clindamycin—Urticaria—Methotrexate—lung cancer	0.000125	0.000356	CcSEcCtD
Clindamycin—CYP3A4—Estrogen metabolism—GSTM1—lung cancer	0.000124	0.0119	CbGpPWpGaD
Clindamycin—Abdominal pain—Methotrexate—lung cancer	0.000124	0.000354	CcSEcCtD
Clindamycin—Body temperature increased—Methotrexate—lung cancer	0.000124	0.000354	CcSEcCtD
Clindamycin—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—lung cancer	0.000122	0.0116	CbGpPWpGaD
Clindamycin—Dyspnoea—Doxorubicin—lung cancer	0.000121	0.000346	CcSEcCtD
Clindamycin—Dyspepsia—Doxorubicin—lung cancer	0.00012	0.000341	CcSEcCtD
Clindamycin—CYP3A4—Estrogen metabolism—CYP1A1—lung cancer	0.000118	0.0112	CbGpPWpGaD
Clindamycin—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000117	0.000335	CcSEcCtD
Clindamycin—Fatigue—Doxorubicin—lung cancer	0.000117	0.000334	CcSEcCtD
Clindamycin—Constipation—Doxorubicin—lung cancer	0.000116	0.000332	CcSEcCtD
Clindamycin—Pain—Doxorubicin—lung cancer	0.000116	0.000332	CcSEcCtD
Clindamycin—Hypersensitivity—Methotrexate—lung cancer	0.000116	0.00033	CcSEcCtD
Clindamycin—CYP3A4—Irinotecan Pathway—APC—lung cancer	0.000113	0.0108	CbGpPWpGaD
Clindamycin—Asthenia—Methotrexate—lung cancer	0.000113	0.000321	CcSEcCtD
Clindamycin—Gastrointestinal pain—Doxorubicin—lung cancer	0.000111	0.000317	CcSEcCtD
Clindamycin—Pruritus—Methotrexate—lung cancer	0.000111	0.000317	CcSEcCtD
Clindamycin—CYP3A4—Xenobiotics—CYP1A1—lung cancer	0.000108	0.0103	CbGpPWpGaD
Clindamycin—Urticaria—Doxorubicin—lung cancer	0.000108	0.000308	CcSEcCtD
Clindamycin—Abdominal pain—Doxorubicin—lung cancer	0.000108	0.000307	CcSEcCtD
Clindamycin—Body temperature increased—Doxorubicin—lung cancer	0.000108	0.000307	CcSEcCtD
Clindamycin—Diarrhoea—Methotrexate—lung cancer	0.000108	0.000306	CcSEcCtD
Clindamycin—CYP3A4—Tamoxifen metabolism—CYP1A1—lung cancer	0.000104	0.00994	CbGpPWpGaD
Clindamycin—Dizziness—Methotrexate—lung cancer	0.000104	0.000296	CcSEcCtD
Clindamycin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—lung cancer	0.000103	0.0098	CbGpPWpGaD
Clindamycin—Hypersensitivity—Doxorubicin—lung cancer	0.0001	0.000286	CcSEcCtD
Clindamycin—Vomiting—Methotrexate—lung cancer	9.99e-05	0.000285	CcSEcCtD
Clindamycin—Rash—Methotrexate—lung cancer	9.91e-05	0.000282	CcSEcCtD
Clindamycin—Dermatitis—Methotrexate—lung cancer	9.9e-05	0.000282	CcSEcCtD
Clindamycin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—lung cancer	9.87e-05	0.00941	CbGpPWpGaD
Clindamycin—Headache—Methotrexate—lung cancer	9.84e-05	0.000281	CcSEcCtD
Clindamycin—Asthenia—Doxorubicin—lung cancer	9.76e-05	0.000278	CcSEcCtD
Clindamycin—Pruritus—Doxorubicin—lung cancer	9.63e-05	0.000274	CcSEcCtD
Clindamycin—Nausea—Methotrexate—lung cancer	9.33e-05	0.000266	CcSEcCtD
Clindamycin—Diarrhoea—Doxorubicin—lung cancer	9.31e-05	0.000265	CcSEcCtD
Clindamycin—Dizziness—Doxorubicin—lung cancer	9e-05	0.000256	CcSEcCtD
Clindamycin—Vomiting—Doxorubicin—lung cancer	8.65e-05	0.000247	CcSEcCtD
Clindamycin—Rash—Doxorubicin—lung cancer	8.58e-05	0.000245	CcSEcCtD
Clindamycin—Dermatitis—Doxorubicin—lung cancer	8.57e-05	0.000244	CcSEcCtD
Clindamycin—Headache—Doxorubicin—lung cancer	8.52e-05	0.000243	CcSEcCtD
Clindamycin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—lung cancer	8.09e-05	0.00771	CbGpPWpGaD
Clindamycin—Nausea—Doxorubicin—lung cancer	8.08e-05	0.00023	CcSEcCtD
Clindamycin—CYP3A4—Tryptophan metabolism—CYP2E1—lung cancer	7.75e-05	0.00739	CbGpPWpGaD
Clindamycin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—lung cancer	7.7e-05	0.00734	CbGpPWpGaD
Clindamycin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—lung cancer	7.37e-05	0.00702	CbGpPWpGaD
Clindamycin—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—lung cancer	7.27e-05	0.00693	CbGpPWpGaD
Clindamycin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—lung cancer	6.27e-05	0.00597	CbGpPWpGaD
Clindamycin—CYP3A4—Tryptophan metabolism—CAT—lung cancer	6.22e-05	0.00593	CbGpPWpGaD
Clindamycin—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—lung cancer	6.18e-05	0.00589	CbGpPWpGaD
Clindamycin—CYP3A4—Biological oxidations—GSTM2—lung cancer	6.04e-05	0.00576	CbGpPWpGaD
Clindamycin—CYP3A4—Biological oxidations—CNDP2—lung cancer	6.04e-05	0.00576	CbGpPWpGaD
Clindamycin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—lung cancer	5.97e-05	0.00569	CbGpPWpGaD
Clindamycin—CYP3A4—Metapathway biotransformation—GSTM2—lung cancer	5.96e-05	0.00568	CbGpPWpGaD
Clindamycin—CYP3A4—Tryptophan metabolism—CYP1A1—lung cancer	5.57e-05	0.00531	CbGpPWpGaD
Clindamycin—CYP3A4—Biological oxidations—CYP2A7—lung cancer	5.46e-05	0.00521	CbGpPWpGaD
Clindamycin—CYP3A4—Metapathway biotransformation—CYP2A7—lung cancer	5.39e-05	0.00514	CbGpPWpGaD
Clindamycin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	5.08e-05	0.00484	CbGpPWpGaD
Clindamycin—CYP3A4—Biological oxidations—GSTA3—lung cancer	4.87e-05	0.00464	CbGpPWpGaD
Clindamycin—CYP3A4—Metapathway biotransformation—GSTA3—lung cancer	4.8e-05	0.00458	CbGpPWpGaD
Clindamycin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	4.5e-05	0.00429	CbGpPWpGaD
Clindamycin—CYP3A4—Biological oxidations—GSTA4—lung cancer	4.45e-05	0.00424	CbGpPWpGaD
Clindamycin—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—lung cancer	4.44e-05	0.00423	CbGpPWpGaD
Clindamycin—CYP3A4—Metapathway biotransformation—GSTA4—lung cancer	4.39e-05	0.00419	CbGpPWpGaD
Clindamycin—CYP3A4—Biological oxidations—GSTA2—lung cancer	4.34e-05	0.00414	CbGpPWpGaD
Clindamycin—CYP3A4—Biological oxidations—GSTA1—lung cancer	4.19e-05	0.00399	CbGpPWpGaD
Clindamycin—CYP3A4—Metapathway biotransformation—AKR1C1—lung cancer	3.95e-05	0.00377	CbGpPWpGaD
Clindamycin—CYP3A4—Biological oxidations—UGT1A1—lung cancer	3.89e-05	0.00371	CbGpPWpGaD
Clindamycin—CYP3A4—Metapathway biotransformation—UGT1A1—lung cancer	3.84e-05	0.00366	CbGpPWpGaD
Clindamycin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	3.65e-05	0.00348	CbGpPWpGaD
Clindamycin—CYP3A4—Tryptophan metabolism—MDM2—lung cancer	3.43e-05	0.00327	CbGpPWpGaD
Clindamycin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	3.36e-05	0.0032	CbGpPWpGaD
Clindamycin—CYP3A4—Biological oxidations—HPGDS—lung cancer	3.31e-05	0.00315	CbGpPWpGaD
Clindamycin—CYP3A4—Biological oxidations—GSTT1—lung cancer	3.21e-05	0.00306	CbGpPWpGaD
Clindamycin—CYP3A4—Biological oxidations—GCLC—lung cancer	3.17e-05	0.00302	CbGpPWpGaD
Clindamycin—CYP3A4—Biological oxidations—CYP2A6—lung cancer	3.17e-05	0.00302	CbGpPWpGaD
Clindamycin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	2.72e-05	0.00259	CbGpPWpGaD
Clindamycin—CYP3A4—Biological oxidations—CYP2E1—lung cancer	2.7e-05	0.00257	CbGpPWpGaD
Clindamycin—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	2.66e-05	0.00254	CbGpPWpGaD
Clindamycin—CYP3A4—Biological oxidations—GSTP1—lung cancer	2.23e-05	0.00212	CbGpPWpGaD
Clindamycin—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	2.19e-05	0.00209	CbGpPWpGaD
Clindamycin—CYP3A4—Biological oxidations—GSTM1—lung cancer	2.04e-05	0.00195	CbGpPWpGaD
Clindamycin—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	2.02e-05	0.00192	CbGpPWpGaD
Clindamycin—CYP3A4—Biological oxidations—CYP1A1—lung cancer	1.94e-05	0.00185	CbGpPWpGaD
Clindamycin—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	1.91e-05	0.00182	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—COL4A3BP—lung cancer	1.71e-05	0.00163	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—AZIN2—lung cancer	1.71e-05	0.00163	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—ATP5H—lung cancer	1.45e-05	0.00138	CbGpPWpGaD
Clindamycin—CYP3A4—Biological oxidations—POMC—lung cancer	1.45e-05	0.00138	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—PLBD1—lung cancer	1.29e-05	0.00123	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—HSD17B10—lung cancer	1.18e-05	0.00113	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—CKB—lung cancer	1.1e-05	0.00105	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—GSTM2—lung cancer	1.03e-05	0.000985	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—CNDP2—lung cancer	1.03e-05	0.000985	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—MTMR3—lung cancer	1e-05	0.000958	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—PGAM1—lung cancer	9.79e-06	0.000933	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—CYP2A7—lung cancer	9.34e-06	0.00089	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—SDC4—lung cancer	9.14e-06	0.000871	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—GSTA3—lung cancer	8.33e-06	0.000794	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—RRM1—lung cancer	8.33e-06	0.000794	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—B4GALT5—lung cancer	7.83e-06	0.000746	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—GSTA4—lung cancer	7.62e-06	0.000726	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—GSTA2—lung cancer	7.42e-06	0.000707	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—GSTA1—lung cancer	7.16e-06	0.000682	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—ABCC3—lung cancer	7.08e-06	0.000675	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—AKR1C1—lung cancer	6.86e-06	0.000654	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—UGT1A1—lung cancer	6.66e-06	0.000634	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—GNG11—lung cancer	6.42e-06	0.000612	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—ALDOA—lung cancer	6.11e-06	0.000582	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—NCOA3—lung cancer	5.93e-06	0.000565	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—ADCY1—lung cancer	5.77e-06	0.00055	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—ABCG2—lung cancer	5.77e-06	0.00055	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—HPGDS—lung cancer	5.66e-06	0.000539	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—ENO2—lung cancer	5.66e-06	0.000539	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—PPP2R1B—lung cancer	5.62e-06	0.000536	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—GSTT1—lung cancer	5.49e-06	0.000523	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—GCLC—lung cancer	5.43e-06	0.000517	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—CYP2A6—lung cancer	5.43e-06	0.000517	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—ENO1—lung cancer	5.14e-06	0.00049	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—CYP2E1—lung cancer	4.61e-06	0.00044	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—NQO1—lung cancer	4.56e-06	0.000435	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—STK11—lung cancer	4.11e-06	0.000392	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—GSTP1—lung cancer	3.81e-06	0.000363	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—CAT—lung cancer	3.7e-06	0.000353	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—ABCB1—lung cancer	3.6e-06	0.000343	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—TYMS—lung cancer	3.54e-06	0.000337	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—GSTM1—lung cancer	3.5e-06	0.000333	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—CYP1A1—lung cancer	3.31e-06	0.000316	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—ERCC2—lung cancer	3.29e-06	0.000313	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—APOA1—lung cancer	2.84e-06	0.000271	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—PIK3CG—lung cancer	2.6e-06	0.000247	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—POMC—lung cancer	2.47e-06	0.000236	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—CREBBP—lung cancer	2.41e-06	0.000229	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—PIK3CD—lung cancer	2.28e-06	0.000218	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—ALB—lung cancer	2.25e-06	0.000215	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—PIK3CB—lung cancer	1.99e-06	0.00019	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—PTGS2—lung cancer	1.97e-06	0.000188	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—PTEN—lung cancer	1.72e-06	0.000164	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—EP300—lung cancer	1.64e-06	0.000156	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—PIK3CA—lung cancer	1.21e-06	0.000116	CbGpPWpGaD
Clindamycin—CYP3A4—Metabolism—AKT1—lung cancer	9.91e-07	9.44e-05	CbGpPWpGaD
